Biolife Solutions (BLFS) Shares Outstanding (Diluted Average) (2011 - 2026)

Biolife Solutions (BLFS) has 12 years of Shares Outstanding (Diluted Average) data on file, last reported at $49.2 million in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 1.82% year-over-year to $49.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.2 million (up 1.82% YoY) and the FY2025 annual result came in at $48.6 million, up 5.6% from the prior year.
• Shares Outstanding (Diluted Average) improved to $49.2 million in Q1 2026 per BLFS's latest filing, from $48.6 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $49.2 million in Q1 2026 and bottomed at $42.4 million in Q3 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $45.7 million (2024), against an average of $45.4 million.
• Peak annual rise in Shares Outstanding (Diluted Average) reached 11.87% in 2022, while the deepest fall reached 2.13% in 2022.
• Tracing BLFS's Shares Outstanding (Diluted Average) over 5 years: stood at $43.1 million in 2022, then rose by 1.5% to $43.7 million in 2023, then increased by 5.37% to $46.1 million in 2024, then climbed by 5.6% to $48.6 million in 2025, then grew by 1.24% to $49.2 million in 2026.
• Per Business Quant, the three latest BLFS Shares Outstanding (Diluted Average) figures stand at $49.2 million (Q1 2026), $48.6 million (Q4 2025), and $47.6 million (Q3 2025).

Peer Comparison